LiNA MEDICAL

LiNA MEDICAL

Glostrup, Denmark· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $45M

Overview

LiNA Medical is a privately held, commercial-stage medical device company with a focused portfolio in minimally invasive gynecology. The company has a long-standing history of product innovation, transitioning from early work in ECG electrodes and electrosurgery to a dedicated gynecology focus, driven by family leadership and significant R&D investment. Its business model centers on direct sales and distributor partnerships, generating revenue from a suite of commercialized devices designed to offer procedural simplicity and cost-effectiveness to healthcare providers globally.

GynecologyWomen's Health

Technology Platform

Applied engineering focused on simplifying surgical technology through cordless operation, single-use systems, and procedural integration for minimally invasive gynecological procedures.

Funding History

2
Total raised:$45M
Series B$30M
Series A$15M

Opportunities

Growth is driven by the global shift towards minimally invasive, outpatient gynecological surgery.
LiNA's simplified, often single-use devices lower capital barriers for hospitals and ambulatory surgical centers, positioning them well for this trend.
Expansion into new geographic markets through its distributor network offers additional revenue potential.

Risk Factors

The company faces intense competition from large, diversified medical device giants with greater resources.
Success is also heavily dependent on maintaining favorable regulatory approvals and reimbursement policies across different countries, which can change unpredictably.

Competitive Landscape

LiNA competes in niche segments of the gynecological device market against major players like Medtronic, Hologic, and Boston Scientific, as well as other specialized companies. Its competitive advantage lies in product simplicity, cost-effectiveness (avoiding capital equipment), and a focused understanding of the gynecological surgeon's workflow, rather than in competing on a full portfolio basis.